オンコリスバイオファーマ(株)の貸借残高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4588/ - -
公表日公表担保貸付残高前週比借入残高（自己）前週比借入残高（転貸）前週比
2023/07/21日証協無担保28,900株0%121,400株0%996,156株0%
2023/07/21日証協有担保2,961,899株0%742,699株0%1,251,299株0%
2023/07/14日証協無担保28,900株0%121,900株0%985,756株0%
2023/07/14日証協有担保3,007,399株0%784,999株0%1,249,510株0%
2023/07/07日証協無担保22,600株0%111,200株0%948,756株0%
2023/07/07日証協有担保2,370,599株0%389,399株0%1,092,599株0%
2023/06/30日証協無担保17,900株0%10,200株0%917,855株0%
2023/06/30日証協有担保2,736,499株0%314,199株0%1,341,899株0%
2023/06/23日証協無担保13,300株0%94,200株0%939,920株0%
2023/06/23日証協有担保1,543,989株0%242,499株0%740,519株0%
2023/06/16日証協無担保12,500株0%94,100株0%942,326株0%
2023/06/16日証協有担保1,556,289株0%244,999株0%734,619株0%
2023/06/09日証協無担保12,000株0%100,400株0%933,026株0%
2023/06/09日証協有担保1,712,489株0%344,099株0%742,919株0%
2023/06/02日証協無担保11,600株0%94,600株0%939,826株0%
2023/06/02日証協有担保1,673,489株0%259,099株0%824,519株0%
2023/05/26日証協無担保11,000株0%95,400株0%951,326株0%
2023/05/26日証協有担保1,641,789株0%238,199株0%802,019株0%
2023/05/19日証協無担保9,600株0%100,100株0%940,925株0%
2023/05/19日証協有担保1,599,989株0%249,299株0%775,119株0%
2023/05/12日証協無担保7,700株0%100,300株0%938,025株0%
2023/05/12日証協有担保1,558,219株0%228,399株0%807,419株0%
2023/05/02日証協無担保7,300株0%103,500株0%939,425株+0.06%
2023/05/02日証協有担保1,545,319株+0.06%233,799株+5.94%801,619株+0.05%
2023/04/28日証協無担保7,300株-1.35%103,500株+0.88%938,825株-0.86%
2023/04/28日証協有担保1,544,319株-1.49%220,699株-6.48%801,219株-2.24%
2023/04/21日証協無担保7,400株+7.25%102,600株-2.29%946,929株+1.92%
2023/04/21日証協有担保1,567,619株-0.94%235,999株-17.94%819,619株-1.09%
2023/04/14日証協無担保6,900株+30.19%105,000株+1.55%929,092株+1.79%
2023/04/14日証協有担保1,582,419株-0.65%287,599株-1%828,619株+0.78%
2023/04/07日証協無担保5,300株0%103,400株-0.1%912,792株+1.26%
2023/04/07日証協有担保1,592,719株-2.48%290,499株+1.47%822,219株-1.99%
2023/03/31日証協無担保0株0%103,500株+0.68%901,392株-0.69%
2023/03/31日証協有担保1,633,219株+72.82%286,299株-1.04%838,919株-0.58%
2023/03/24日証協無担保0株0%102,800株-0.87%907,692株+1.32%
2023/03/24日証協有担保945,019株+4.14%289,299株+6.95%843,819株+6.41%
2023/03/17日証協無担保0株0%103,700株-1.61%895,860株+0.47%
2023/03/17日証協有担保907,419株+6.82%270,499株+3.36%793,019株+4.6%

※株式分割は考慮していませんのでご注意ください。

Page Top